documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
413 rows where docket_id = "FDA-2016-N-3389" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 3
- Supporting & Related Material 410
- Notice 2
- Other 1
agency_id 1
- FDA 413
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2016-N-3389-0463 | FDA | None FDA-2016-N-3389 | Table of Contents Appendix of Copyrighted Footnote and Endnote Materials Copyrighted Materials Cited in Footnotes re: Comment from The Food Lawyers® | Supporting & Related Material | Background Material | 2017-02-28T05:00:00Z | 2017 | 2 | 2017-02-28T16:59:26Z | 0 | 0 | 09000064824e1800 | |||
| FDA-2016-N-3389-0459 | FDA | None FDA-2016-N-3389 | Expert Panel Report on the Intrinsic and Intact Dietary Fiber Status of Grain Millers Oat Fiber January 23, 2017 re: Comment from The Food Lawyers® | Supporting & Related Material | Background Material | 2017-02-24T05:00:00Z | 2017 | 2 | 2017-02-24T20:04:27Z | 0 | 0 | 09000064824db147 | |||
| FDA-2016-N-3389-0460 | FDA | None FDA-2016-N-3389 | Exhibit D List of Technical Materials Provided to Expert Panel re: Comment from The Food Lawyers® | Supporting & Related Material | Background Material | 2017-02-24T05:00:00Z | 2017 | 2 | 2017-02-24T20:38:48Z | 0 | 0 | 09000064824db0b2 | |||
| FDA-2016-N-3389-0461 | FDA | None FDA-2016-N-3389 | Exhibit E Grain Millers' Proprietary Production Process that Retains All Lignin and Other Plant Components Intrinsic and Intact re: Comment from The Food Lawyers® | Supporting & Related Material | Background Material | 2017-02-24T05:00:00Z | 2017 | 2 | 2017-02-24T20:45:35Z | 0 | 0 | 09000064824db0b3 | |||
| FDA-2016-N-3389-0462 | FDA | None FDA-2016-N-3389 | Reference Materials for Endnotes 1-26 Supporting Expert Panel Report on the Intrinsic and Intact Dietary Fiber Status of Grain Millers Oat Fiber re: Comment from The Food Lawyers® | Supporting & Related Material | Background Material | 2017-02-24T05:00:00Z | 2017 | 2 | 2017-02-24T21:46:22Z | 0 | 0 | 09000064824db0b4 | |||
| FDA-2016-N-3389-0458 | FDA | None FDA-2016-N-3389 | Table of Contents for Attachment "B" Expert Panel Report on the Intrinsic and Intact Dietary Fiber Status of Grain Millers Oat Fiber re: Comment from The Food Lawyers® | Supporting & Related Material | Background Material | 2017-02-24T05:00:00Z | 2017 | 2 | 2017-02-24T19:49:56Z | 0 | 0 | 09000064824db146 | |||
| FDA-2016-N-3389-0457 | FDA | None FDA-2016-N-3389 | Reference Materials for Endnotes 1-11 Supporting Attachment "A" re: Comment from The Food Lawyers® | Supporting & Related Material | Background Material | 2017-02-23T05:00:00Z | 2017 | 2 | 2017-02-23T17:32:05Z | 0 | 0 | 09000064824d8012 | |||
| FDA-2016-N-3389-0454 | FDA | None FDA-2016-N-3389 | Reference Materials for Footnotes 1-20 Contained in The Food Lawyers Comment | Supporting & Related Material | Background Material | 2017-02-23T05:00:00Z | 2017 | 2 | 2017-02-23T17:25:46Z | 0 | 0 | 09000064824d8139 | |||
| FDA-2016-N-3389-0456 | FDA | None FDA-2016-N-3389 | Attachment "A" Grain Millers Milling Process vs. Patented Hydrogen Peroxide and Similar Methods re: Comment from The Food Lawyers® | Supporting & Related Material | Background Material | 2017-02-23T05:00:00Z | 2017 | 2 | 2017-02-23T17:22:25Z | 0 | 0 | 09000064824d8011 | |||
| FDA-2016-N-3389-0453 | FDA | None FDA-2016-N-3389 | Table of Contents re: Comment from The Food Lawyers® | Supporting & Related Material | Background Material | 2017-02-23T05:00:00Z | 2017 | 2 | 2017-02-23T16:43:41Z | 0 | 0 | 09000064824d8138 | |||
| FDA-2016-N-3389-0455 | FDA | None FDA-2016-N-3389 | Table of Contents for Attachment "A" Grain Millers Milling Process vs. Patented Hydrogen Peroxide and Similar Methods re: Comment from The Food Lawyers® | Supporting & Related Material | Background Material | 2017-02-23T05:00:00Z | 2017 | 2 | 2017-02-23T17:20:29Z | 0 | 0 | 09000064824d7fd3 | |||
| FDA-2016-N-3389-0448 | FDA | None FDA-2016-N-3389 | Appendix V: Nutrient Analysis of Gum Acacia re: Comment from Keller and Heckman LLP on behalf of Nexira, TIC Gums, et al | Supporting & Related Material | Background Material | 2017-02-17T05:00:00Z | 2017 | 2 | 2017-02-17T17:15:03Z | 0 | 0 | 09000064824caff0 | |||
| FDA-2016-N-3389-0445 | FDA | None FDA-2016-N-3389 | Appendix II: Article on Gummosis re: Comment from Keller and Heckman LLP on behalf of Nexira, TIC Gums, et al | Supporting & Related Material | Background Material | 2017-02-17T05:00:00Z | 2017 | 2 | 2017-02-17T17:08:44Z | 0 | 0 | 09000064824cafed | |||
| FDA-2016-N-3389-0444 | FDA | None FDA-2016-N-3389 | Appendix I: Manufacturing Process of Gum Acacia re: Comment from Keller and Heckman LLP on behalf of Nexira, TIC Gums, et al | Supporting & Related Material | Background Material | 2017-02-17T05:00:00Z | 2017 | 2 | 2017-02-17T17:07:03Z | 0 | 0 | 09000064824cafda | |||
| FDA-2016-N-3389-0450 | FDA | None FDA-2016-N-3389 | Appendix VII: English Translation of Torres et al. 2006 re: Comment from Keller and Heckman LLP on behalf of Nexira, TIC Gums, et al | Supporting & Related Material | Background Material | 2017-02-17T05:00:00Z | 2017 | 2 | 2017-02-17T17:20:41Z | 0 | 0 | 09000064824caff2 | |||
| FDA-2016-N-3389-0447 | FDA | None FDA-2016-N-3389 | Appendix IV: Article on Traditional Food Use of Gum Acacia re: Comment from Keller and Heckman LLP on behalf of Nexira, TIC Gums, et al | Supporting & Related Material | Background Material | 2017-02-17T05:00:00Z | 2017 | 2 | 2017-02-17T17:12:48Z | 0 | 0 | 09000064824cafef | |||
| FDA-2016-N-3389-0449 | FDA | None FDA-2016-N-3389 | Appendix VI: Akeo Paper- Japanese and English Translation re: Comment from Keller and Heckman LLP on behalf of Nexira, TIC Gums, et al | Supporting & Related Material | Background Material | 2017-02-17T05:00:00Z | 2017 | 2 | 2017-02-17T17:18:40Z | 0 | 0 | 09000064824caff1 | |||
| FDA-2016-N-3389-0446 | FDA | None FDA-2016-N-3389 | Appendix III: Letter from Health Canada regarding Gum Acacia as Dietary Fiber re: Comment from Keller and Heckman LLP on behalf of Nexira, TIC Gums, et al | Supporting & Related Material | Background Material | 2017-02-17T05:00:00Z | 2017 | 2 | 2017-02-17T17:10:23Z | 0 | 0 | 09000064824cafee | |||
| FDA-2016-N-3389-0451 | FDA | None FDA-2016-N-3389 | Appendix VIII: Unpublished Australian Study- Confidential re: Comment from Keller and Heckman LLP on behalf of Nexira, TIC Gums, et al | Supporting & Related Material | Background Material | 2017-02-17T05:00:00Z | 2017 | 2 | 2017-02-17T17:22:37Z | 0 | 0 | 09000064824caff3 | |||
| FDA-2016-N-3389-0440 | FDA | None FDA-2016-N-3389 | Attachment I Chemical Equivalence re: Comment from Keller and Heckman LLP on behalf of Roquette | Supporting & Related Material | Background Material | 2017-02-16T05:00:00Z | 2017 | 2 | 2017-02-16T15:42:36Z | 0 | 0 | 09000064824c7516 | |||
| FDA-2016-N-3389-0441 | FDA | None FDA-2016-N-3389 | Attachment 2 Unpublished Studies on Nutriose (#1-8) re: Comment from Keller and Heckman LLP on behalf of Roquette | Supporting & Related Material | Background Material | 2017-02-16T05:00:00Z | 2017 | 2 | 2017-02-16T15:45:18Z | 0 | 0 | 09000064824c7517 | |||
| FDA-2016-N-3389-0408 | FDA | None FDA-2016-N-3389 | Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request For Scientific Data, Information, and Comments; Reopening of Comment Period | Notice | Extension of Comment Period | 2017-01-13T05:00:00Z | 2017 | 1 | 2017-01-13T05:00:00Z | 2017-02-14T04:59:59Z | 2017-03-04T02:01:35Z | 2017-00725 | 0 | 0 | 090000648247042b |
| FDA-2016-N-3389-0407 | FDA | None FDA-2016-N-3389 | List of Cited References re: Comment from Anonymous | Supporting & Related Material | Background Material | 2017-01-12T05:00:00Z | 2017 | 1 | 2017-01-12T19:57:52Z | 0 | 0 | 0900006482466678 | |||
| FDA-2016-N-3389-0394 | FDA | None FDA-2016-N-3389 | Request to Extend Comment Period from Grocery Manufacturers Association | Other | Electronic Regulation from Form | 2016-12-29T05:00:00Z | 2016 | 12 | 2016-12-29T05:00:00Z | 2016-12-29T17:19:26Z | 0 | 0 | 0900006482432fb6 | ||
| FDA-2016-N-3389-0008 | FDA | None FDA-2016-N-3389 | Reference 02-05 Evaluation of satiety enhancement, including compensation, by blends of gum arabic. A methodological approach re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T17:52:51Z | 0 | 0 | 090000648239903a | |||
| FDA-2016-N-3389-0023 | FDA | None FDA-2016-N-3389 | Reference 02-20 In vivo imaging of intragastric and its effect on satiety in humans re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T17:57:02Z | 0 | 0 | 09000064823990d7 | |||
| FDA-2016-N-3389-0151 | FDA | None FDA-2016-N-3389 | Reference 02-148 Effects of consumption a bread contains agave or chicory inulin on lipids and blood pressure in patients with cardiovascular risk factors re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:17:56Z | 0 | 0 | 09000064823996bd | |||
| FDA-2016-N-3389-0154 | FDA | None FDA-2016-N-3389 | Reference 02-151 Inulin and oligofructose What are they re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:18:36Z | 0 | 0 | 09000064823996c2 | |||
| FDA-2016-N-3389-0158 | FDA | None FDA-2016-N-3389 | Reference 02-155 Gut hormone release and appetite regulation in healthy non-obese participants following oligofructose intake A dose-escalation study re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:19:10Z | 0 | 0 | 09000064823996ef | |||
| FDA-2016-N-3389-0189 | FDA | None FDA-2016-N-3389 | Reference 02-186 Microbiota benefits after inulin and partially hydrolized guar gum supplementation – a randomized clinical trial in constipated women re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:24:44Z | 0 | 0 | 0900006482399739 | |||
| FDA-2016-N-3389-0330 | FDA | None FDA-2016-N-3389 | Reference 02-328 Suppressive effect of resistant maltodextrin on postprandial blood triglycerol elevation re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:46:42Z | 0 | 0 | 090000648239986a | |||
| FDA-2016-N-3389-0343 | FDA | None FDA-2016-N-3389 | Reference 02-342 A double-blind placebo-controlled clinical trial compares the cholesterol lowering effects of two different soy protein preparations re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:48:15Z | 0 | 0 | 090000648239989c | |||
| FDA-2016-N-3389-0350 | FDA | None FDA-2016-N-3389 | Reference 02-349 Effects of some cereal brans and textured vegetable protein on plasma lipids re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:48:59Z | 0 | 0 | 09000064823998b4 | |||
| FDA-2016-N-3389-0120 | FDA | None FDA-2016-N-3389 | Reference 02-117 Acute effects of a herb extract formulation and inulin fibre on appetite, energy intake and food choice re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:14:07Z | 0 | 0 | 0900006482399943 | |||
| FDA-2016-N-3389-0050 | FDA | None FDA-2016-N-3389 | Reference 02-46 Alteration of the fiber and lipid components of a defined-formula diet effects on stool characteristics, nutrient digestibility, mineral balance re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:02:34Z | 0 | 0 | 0900006482399510 | |||
| FDA-2016-N-3389-0111 | FDA | None FDA-2016-N-3389 | Reference 02-108 Effect of inulin and fructo-oligosaccharide on the prevention of acute radiation enteritis in patients with gynecological cancer and impact on quality-of-life re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:13:11Z | 0 | 0 | 090000648239964b | |||
| FDA-2016-N-3389-0213 | FDA | None FDA-2016-N-3389 | Reference 02-209 Long-term blood cholesterol-lowering effects of a dietary fiber supplement re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:28:32Z | 0 | 0 | 09000064823999f6 | |||
| FDA-2016-N-3389-0215 | FDA | None FDA-2016-N-3389 | Reference 02-211 Decreased postprandial thermogenesis and fat oxidation but increased fullness after a high-fiber meal compared with a low-fiber meal re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:28:52Z | 0 | 0 | 09000064823999f8 | |||
| FDA-2016-N-3389-0238 | FDA | None FDA-2016-N-3389 | Reference 02-235 Volume of food consumed affect satiety in men re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:32:49Z | 0 | 0 | 0900006482399a31 | |||
| FDA-2016-N-3389-0242 | FDA | None FDA-2016-N-3389 | Reference 02-239 Attenuated response of the serum triglyceride concentration to ingestion of a chocolate containing polydextrose and lactitol in place of sugar re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:33:24Z | 0 | 0 | 0900006482399a35 | |||
| FDA-2016-N-3389-0259 | FDA | None FDA-2016-N-3389 | Reference 02-256 Effect of carbohydrate digestibility on appetite and its relationship to postprandial blood glucose and insulin levels re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:36:16Z | 0 | 0 | 0900006482399a66 | |||
| FDA-2016-N-3389-0272 | FDA | None FDA-2016-N-3389 | Reference 02-269 Acute ingestion of resistant starch reduces food intake in healthy adults re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:38:48Z | 0 | 0 | 0900006482399a97 | |||
| FDA-2016-N-3389-0276 | FDA | None FDA-2016-N-3389 | Reference 02-273 Interaction between physical structure and amyloseamylopectin ratio of foods on postprandial glucose and insulin responses in healthy subjects re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:39:16Z | 0 | 0 | 0900006482399a9b | |||
| FDA-2016-N-3389-0227 | FDA | None FDA-2016-N-3389 | Reference 02-224 Effects of polydextrose supplementation on different faecal parameters in healthy volunteers re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:30:30Z | 0 | 0 | 0900006482399790 | |||
| FDA-2016-N-3389-0266 | FDA | None FDA-2016-N-3389 | Reference 02-263 Effect of long-term consumption of amylose vs amylopectin starch on metabolic variables in human subjects re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:37:50Z | 0 | 0 | 09000064823997db | |||
| FDA-2016-N-3389-0308 | FDA | None FDA-2016-N-3389 | Reference 02-305 Design criteria for studies examining individual fatty acid effects on cardiovascular disease risk factors human and animal studies re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:43:49Z | 0 | 0 | 0900006482399827 | |||
| FDA-2016-N-3389-0304 | FDA | None FDA-2016-N-3389 | Reference 02-301 Physiological effects of resistant starches on fecal bulk, short chain fatty acids, blood lipids and glycemic index re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:43:19Z | 0 | 0 | 0900006482399ad7 | |||
| FDA-2016-N-3389-0367 | FDA | None FDA-2016-N-3389 | Reference 02-366 Serum lipid and fecal bile acid changes with cereal, vegetable, and sugar-beet fiber feeding re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:51:48Z | 0 | 0 | 0900006482399bb2 | |||
| FDA-2016-N-3389-0372 | FDA | None FDA-2016-N-3389 | Reference 02-371 The effects of two dietary fiber supplements on gastrointestinal transit, stool weight and frequency re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:53:25Z | 0 | 0 | 0900006482399bb7 | |||
| FDA-2016-N-3389-0018 | FDA | None FDA-2016-N-3389 | Reference 02-15 Fiber and prebiotics mechanism and health benefits re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T17:56:23Z | 0 | 0 | 09000064823990d2 | |||
| FDA-2016-N-3389-0021 | FDA | None FDA-2016-N-3389 | Reference 02-18 Ascophyllum nodosum enriched bread reduces subsequent energy intake with no effect on post-prandial glucose and cholesterol in healthy, overweight males re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T17:56:47Z | 0 | 0 | 09000064823990d5 | |||
| FDA-2016-N-3389-0024 | FDA | None FDA-2016-N-3389 | Reference 02-21 Can alginate-based preloads increase weight loss beyond calorie restriction A pilot study in obese individuals re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T17:57:08Z | 0 | 0 | 09000064823990d8 | |||
| FDA-2016-N-3389-0036 | FDA | None FDA-2016-N-3389 | 02-33 Differences in satiety effects of alginate- and whey protein-based foods re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T17:59:04Z | 0 | 0 | 09000064823990f2 | |||
| FDA-2016-N-3389-0039 | FDA | None FDA-2016-N-3389 | 02-35 The effects of bulking, viscous and gel-forming dietary fibres on satiation re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:00:20Z | 0 | 0 | 09000064823990f5 | |||
| FDA-2016-N-3389-0011 | FDA | None FDA-2016-N-3389 | Reference 02-08 Role of water-soluble dietary fiber in the management of elevated plasma cholesterol in healthy subjects re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T17:53:16Z | 0 | 0 | 09000064823993af | |||
| FDA-2016-N-3389-0028 | FDA | None FDA-2016-N-3389 | Reference 02-25 Effect of sodium alginate addition to chocolate milk on glycemia, insulin, appetite and food intake in healthy adult men re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T17:57:38Z | 0 | 0 | 09000064823993eb | |||
| FDA-2016-N-3389-0033 | FDA | None FDA-2016-N-3389 | Reference 02-30 Daily ingestion of alginate reduces energy intake in free-living subjects re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T17:58:12Z | 0 | 0 | 09000064823993f0 | |||
| FDA-2016-N-3389-0100 | FDA | None FDA-2016-N-3389 | Reference 02-96 Inulin controls inflammation and metabolic endotoxemia in women with type 2 diabetes mellitus a randomized-controlled clinical trial re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:09:26Z | 0 | 0 | 09000064823994e2 | |||
| FDA-2016-N-3389-0135 | FDA | None FDA-2016-N-3389 | Reference 02-132 Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:15:40Z | 0 | 0 | 0900006482399695 | |||
| FDA-2016-N-3389-0137 | FDA | None FDA-2016-N-3389 | Reference 02-134 Effects of inulin on faecal bifidobacteria in human subjects re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:16:03Z | 0 | 0 | 0900006482399697 | |||
| FDA-2016-N-3389-0334 | FDA | None FDA-2016-N-3389 | Reference 02-332 Design criteria for studies examining individual fatty acid effects on cardiovascular disease risk factors human and animal studies re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:47:08Z | 0 | 0 | 0900006482399882 | |||
| FDA-2016-N-3389-0346 | FDA | None FDA-2016-N-3389 | Reference 02-345 Effect of soya and cellulose fibers on postprandial glycemic response in type II diabetic patients re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:48:34Z | 0 | 0 | 090000648239989f | |||
| FDA-2016-N-3389-0356 | FDA | None FDA-2016-N-3389 | Reference 02-355 Effects of soy polysaccharide on postprandial plasma glucose, insulin, glucagon, pancreatic polypeptide, somatostatin, and triglyceride in obese diabetic patients re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:50:32Z | 0 | 0 | 09000064823998ba | |||
| FDA-2016-N-3389-0363 | FDA | None FDA-2016-N-3389 | Reference 02-362 Reduced glycemic response to beet-fibre meal in non-insulin-dependent diabetics and its relation to plasma levels of pancreatic and gastrointestinal hormones re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:51:18Z | 0 | 0 | 09000064823998d1 | |||
| FDA-2016-N-3389-0178 | FDA | None FDA-2016-N-3389 | Reference 02-175 Chicory inulin does not increase stool weight or speed up intestinal transit time in healthy male subjects re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:23:09Z | 0 | 0 | 0900006482399994 | |||
| FDA-2016-N-3389-0381 | FDA | None FDA-2016-N-3389 | Reference 02-380 Metabolic characteristics of healthy adult males as affected by ingestion of a liquid nutritional formula re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:57:36Z | 0 | 0 | 0900006482399bc9 | |||
| FDA-2016-N-3389-0001 | FDA | None FDA-2016-N-3389 | Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Notice | Request for Comments | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T05:00:00Z | 2017-01-10T04:59:59Z | 2017-01-13T02:00:53Z | 2016-27950 | 0 | 0 | 09000064823b9adb |
| FDA-2016-N-3389-0114 | FDA | None FDA-2016-N-3389 | Reference 02-111 Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:13:31Z | 0 | 0 | 0900006482399900 | |||
| FDA-2016-N-3389-0115 | FDA | None FDA-2016-N-3389 | Reference 02-112 Prebiotics consumption modifies diastolic blood pressure, but does not affect serum lipids concentratoin in volunteers with ischemic heart disease re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:13:38Z | 0 | 0 | 0900006482399901 | |||
| FDA-2016-N-3389-0144 | FDA | None FDA-2016-N-3389 | Reference 02-141 Fructooligosaccharide (FOS) supplementation in type 2 diabetic adults improves systolic blood pressure, serum lipid, and gut microbiota re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:16:54Z | 0 | 0 | 090000648239995d | |||
| FDA-2016-N-3389-0163 | FDA | None FDA-2016-N-3389 | Reference 02-160 Effects of oligofructose-enriched inulin prebiotic supplementation on the lipid profile and inflammation in women with type 2 diabetes re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:20:49Z | 0 | 0 | 0900006482399976 | |||
| FDA-2016-N-3389-0080 | FDA | None FDA-2016-N-3389 | Reference 02-76 Metabolic characteristics of healthy adult males as affected by ingestion of a liquid nutritional formula containing fish oil, oligosaccharides, gum Arabic re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:07:03Z | 0 | 0 | 0900006482399563 | |||
| FDA-2016-N-3389-0093 | FDA | None FDA-2016-N-3389 | Reference 02-89 Consuming foods with added oligofructose improves stool frequency a randomized trial in healthy young adults re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:08:39Z | 0 | 0 | 090000648239958d | |||
| FDA-2016-N-3389-0107 | FDA | None FDA-2016-N-3389 | Reference 02-103 GRAS Notification 44 re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:10:56Z | 0 | 0 | 09000064823995af | |||
| FDA-2016-N-3389-0110 | FDA | None FDA-2016-N-3389 | Reference 02-107 Tolerance and the effect of high doses of wheat bran extract, containing arabinoxylan-oligosaccharides, and oligofructose on faecal output re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:11:22Z | 0 | 0 | 090000648239964a | |||
| FDA-2016-N-3389-0247 | FDA | None FDA-2016-N-3389 | Reference 02-244 Glycemic responses to sweetened dried and raw cranberries in human with type 2 diabetes re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:34:09Z | 0 | 0 | 0900006482399a4a | |||
| FDA-2016-N-3389-0220 | FDA | None FDA-2016-N-3389 | Reference 02-217 Snacks containing whey protein and polydextrose induce a sustained reduction in daily energy intake over 2 wk under free-living conditions re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:29:37Z | 0 | 0 | 0900006482399789 | |||
| FDA-2016-N-3389-0223 | FDA | None FDA-2016-N-3389 | Reference 02-220 The effects of oligofructose and polydextrose on metabolic control parameters in type-2 diabetes re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:29:57Z | 0 | 0 | 090000648239978c | |||
| FDA-2016-N-3389-0228 | FDA | None FDA-2016-N-3389 | Reference 02-225 Consuming polydextrose in a mid-morning snack increases acute satiety measurements and reduces subsequent energy intake at lunch in healthy human subjects re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:30:38Z | 0 | 0 | 0900006482399791 | |||
| FDA-2016-N-3389-0322 | FDA | None FDA-2016-N-3389 | Reference 02-319 Fermentable fibers do not affect satiety or food intake by women who do not practice restrained eating re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:45:30Z | 0 | 0 | 090000648239984c | |||
| FDA-2016-N-3389-0388 | FDA | None FDA-2016-N-3389 | 02-320 Resistant starch type 4-enriched diet lowered blood cholesterols and improved body composition in a double blind cross-over intervention re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:58:30Z | 0 | 0 | 090000648239984d | |||
| FDA-2016-N-3389-0287 | FDA | None FDA-2016-N-3389 | Reference 02-284 Combining wheat bran with resistant starch has more beneficial effects on fecal indexes than does wheat bran alone re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:40:58Z | 0 | 0 | 0900006482399ab4 | |||
| FDA-2016-N-3389-0293 | FDA | None FDA-2016-N-3389 | Reference 02-290 Comparative study of the acute effects of resistant starch and dietary fibers on metabolic indexes in men re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:41:45Z | 0 | 0 | 0900006482399ac4 | |||
| FDA-2016-N-3389-0314 | FDA | None FDA-2016-N-3389 | Reference 02-311 Evaluation of the effect of four fibers on laxation, gastrointestinal tolerance and serum markers in healthy humans re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:44:34Z | 0 | 0 | 0900006482399afd | |||
| FDA-2016-N-3389-0365 | FDA | None FDA-2016-N-3389 | Reference 02-364 Blood glucose response to pea fiber comparisons with sugar beet fiber and wheat bran re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:51:33Z | 0 | 0 | 0900006482399bb0 | |||
| FDA-2016-N-3389-0376 | FDA | None FDA-2016-N-3389 | Reference 02-375 A novel source of wheat fiber and protein effects on fecal bulk and serum lipids re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:56:07Z | 0 | 0 | 0900006482399bc4 | |||
| FDA-2016-N-3389-0378 | FDA | None FDA-2016-N-3389 | Reference 02-377 The dietary effects of xanthan gum in man re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:57:14Z | 0 | 0 | 0900006482399bc6 | |||
| FDA-2016-N-3389-0029 | FDA | None FDA-2016-N-3389 | Reference 02-26 Effects of a combination fiber system on appetite and energy intake in overweight humans re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T17:57:44Z | 0 | 0 | 09000064823993ec | |||
| FDA-2016-N-3389-0061 | FDA | None FDA-2016-N-3389 | Reference 02-57 Galactooligosacchraide supplementation reduces stress-induced gastrointestinal dysfunction and days of cold or flu a randomized, double-blind, controlled trial re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:04:28Z | 0 | 0 | 090000648239941e | |||
| FDA-2016-N-3389-0086 | FDA | None FDA-2016-N-3389 | Reference 02-82 The effects of oligofructose on metabolic control parameters in type-2 diabetes. re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:07:45Z | 0 | 0 | 090000648239943c | |||
| FDA-2016-N-3389-0002 | FDA | None FDA-2016-N-3389 | Scientific Evaluation of the Evidence on the Beneficial Physiological Effects of Isolated or Synthetic Non-digestible Carbohydrates Submitted as a Citizen Petition (21 CFR 10.30): Guidance for Industry | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T16:03:01Z | 0 | 0 | 09000064823bc576 | |||
| FDA-2016-N-3389-0051 | FDA | None FDA-2016-N-3389 | Reference 02-47 Therapeutic effects of marine collagen peptides on re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:02:47Z | 0 | 0 | 0900006482399511 | |||
| FDA-2016-N-3389-0067 | FDA | None FDA-2016-N-3389 | Reference 02-63 A mixture of trans-galactooligosaccharides reduced markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:05:15Z | 0 | 0 | 0900006482399543 | |||
| FDA-2016-N-3389-0071 | FDA | None FDA-2016-N-3389 | Reference 02-67 Short-term effect of bedtime consumption of fermented milk supplemented with calcium, inulin-type fructans and caseinphosphopetides on bone metabolism re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:05:43Z | 0 | 0 | 0900006482399547 | |||
| FDA-2016-N-3389-0073 | FDA | None FDA-2016-N-3389 | Reference 02-69 Bacterial fermentation of fructooligosaccharides and resistant starch in patients with an ileal pouch-anal anastomosis re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:06:01Z | 0 | 0 | 090000648239955c | |||
| FDA-2016-N-3389-0104 | FDA | None FDA-2016-N-3389 | Reference 02-100 Insight into the prebiotic concept lessons from an exploratory, double blind intervention study with inulin type fructans in obese women re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:10:37Z | 0 | 0 | 09000064823995a8 | |||
| FDA-2016-N-3389-0237 | FDA | None FDA-2016-N-3389 | Reference 02-234 Polydextrose its impact on short-term food intake and subjective feelings of satiety in males – a randomized controlled cross-over study re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:32:42Z | 0 | 0 | 0900006482399a30 | |||
| FDA-2016-N-3389-0249 | FDA | None FDA-2016-N-3389 | Reference 02-246 Digestions and physiological properties of resistant starch in the human large bowel re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:34:27Z | 0 | 0 | 0900006482399a51 | |||
| FDA-2016-N-3389-0229 | FDA | None FDA-2016-N-3389 | Reference 02-226 Studies on the effects of polydextrose intake on physiologic functions in Chinese people re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:30:43Z | 0 | 0 | 09000064823997ae | |||
| FDA-2016-N-3389-0235 | FDA | None FDA-2016-N-3389 | Reference 02-232 Postprandial effects of polydextrose on satiety hormone responses and subjective feelings of appetite in obese participants re Evaluation of the Beneficial Physiological Effects of Isolated or Synthetic Non-Digestible Carbohydrates; Request for Scientific Data, Information, and Comments | Supporting & Related Material | Background Material | 2016-11-23T05:00:00Z | 2016 | 11 | 2016-11-23T18:32:17Z | 0 | 0 | 09000064823997b4 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;